Methotrexate also can cause hepatotoxicity and neutropenia. In 2012, the FDA approved glucarpidase as an antidote to reduce methotrexate levels. However, its use in practice has varied due to high ...

Medicare covers immunotherapy treatment for cancer. Out-of-pocket costs will vary, depending on the Medicare plan a person has and whether or not they have supplemental insurance. If a person has ...

"The CARES-oo5 study showed a clinically meaningful and statistically significant improvement in the primary endpoint of PFS for unresectable HCC who received TACE plus immunotherapy-based ...

A research team made a pivotal discovery in the field of cancer immunotherapy. The team identified a specific population of immune cells that play a critical role in successful treatment of ...

The number of cancer cases being diagnosed in India every year is a whopping 14 lakh. Immunotherapy research and treatment in the country has come a long way, making it an effective treatment ...

Get Instant Summarized Text (Gist) A clinical trial demonstrated that combining chemotherapy with immunotherapy significantly improves treatment outcomes for diffuse large B-cell lymphoma (DLBCL ...

The present immune therapy was focused on the immune checkpoint blockade or Chimeric Antigen Receptor T-Cell Immunotherapy (CART) transfer, but how to activate the innate immune system to antitumor ...

With that being said, investigators then evaluated the effect of glucarpidase on outcomes like kidney recovery, neutropenia, hepatotoxicity, mucositis, and mortality among patients with MTX-associated ...

Prophylactic measures are crucial to reduce infection-related morbidity and mortality in MM patients, especially before immunotherapy becomes widespread. The study provides a baseline for ...